$88.34
+1.90 (+2.20%)
USD · as of 2026-08-19 · marketstack
Clinical trials
catalyst calendar across sponsors →Studies where GMED is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
11 interventional · 5 observational · 6 with posted results
Held by 13 tracked-famous managers (Holocene Advisors, LP, Bridgewater Associates, LP, GABELLI FUNDS LLC, RENAISSANCE TECHNOLOGIES LLC, MARSHALL WACE, LLP, +8 more) · FINRA short interest 4.9 days to cover (settled 2026-07-31) · insider 90d: 0 buys / 1 sells · government filings 180d: 1 congress / 0 executive
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Readout in | Updated |
|---|---|---|---|---|---|---|---|---|
| REFLECT Scoliosis System Post Approval StudyNCT06298812Primary Probable BenefitOpen-label · Treatment | Not applicable | Recruiting | Device: REFLECT Scoliosis Correction System | Idiopathic Scoliosis | 100 | 2027-03-31 | in 223 d | 2026-02-13 |
| A Retrospective Review: Outcomes of the REFLECT™ System for Idiopathic ScoliosisNCT07589023observationalREFLECT Cord Breakage/Separation | — | Not yet recruiting | Device: Scoliosis Correction System, Scoliosis Correction System | Idiopathic Scoliosis | 100 | 2027-01-30 | in 163 d | 2026-05-15 |
| Amnios™ RT Outcomes StudyNCT04088383Visual Analog Scale (VAS) Foot Pain ScoreRandomized · Double-masked · Treatment | Not applicable | Completed | Other: Amnios™ RT, Saline | Plantar Fasciitis | 150 | 2022-11-30actual | — | 2023-02-23 |
| Prospective Robotic Global Research Study (PROGRESS)NCT04257279Numeric Rating ScaleOpen-label · Treatment | Not applicable | Unknown status | Procedure: ExcelsiusGPS™ | Lumbar Disc Disease | 200 | Dec 2021 | — | 2021-10-19 |
| Patient Outcomes Using an Expandable SpacerNCT03162666observationalChange in Radiographic Analysis | — | Withdrawnsponsor's stated reason: The participating party (Rush) stopped the study because of logistic issues. | Device: ALTERA | Degenerative Disc Disease | 0 | 2020-11-06 | — | 2021-08-23 |
| Treatment of Sacroiliac Dysfunction With SI-LOK® Sacroiliac Joint Fixation SI-SI-LOKNCT01861899observationalRadiographic Evaluation | — | Completed | Device: SI-LOK | Joint Dysfunction | 46 | 2018-07-05actual | — | 2020-09-11 |
| Preliminary Investigation of ViaShield™ Amnion Patch as an Anti-Adhesive Barrier in HemicraniectomiesNCT03371316AdhesionOpen-label · Treatment | Not applicable | Withdrawnsponsor's stated reason: Site is no longer participating in study | Biological: ViaShield | Hemicraniectomies | 0 | 2018-01-30actual | — | 2018-02-15 |
| A Pivotal Study of a Facet Replacement System to Treat Spinal StenosisNCT00401518results2020-09-10Measure of Pain/Disability Using the Zurich Claudication Questionnaire (ZCQ) Physical Function ScoreRandomized · Single-masked · TreatmentStudy Protocol and Statistical Analysis Plan ↗ | Not applicable | Completed | Device: Non-randomized ACADIA® Facet Replacement System, Randomized ACADIA® Facet Replacement System, Randomized Instrumented posterolateral fusion (PLF) | Lumbar Spinal Stenosis | 390 | Aug 2017actual | — | 2020-09-10 |
| TRIUMPH Lumbar Artificial Disc IDE: A Pilot StudyNCT01198470results2018-10-02Number of Participants With a Change of at Least 15 Points in Pain/Disability Using the Oswestry Disability Index (ODI) Score at 24 Months Compared With the Score at BaselineOpen-label · Treatment | Not applicable | Completed | Device: TRIUMPH® Lumbar Artificial Disc | Lumbar Degenerative Disc Disease | 20 | Dec 2016actual | — | 2018-10-02 |
| Proximal Junctional Kyphosis Following Long Instrumented Spinal Fusion: The Effect of Implant SelectionNCT01441999Evidence of Proximal Junction Kyphosis as determined by radiographic measurements during follow up visitsRandomized · Single-masked · Prevention | Not applicable | Withdrawnsponsor's stated reason: principal investigator decision | Device: Less rigid rod, Rigid Rod | Kyphosis | 0 | Dec 2016actual | — | 2019-08-02 |
| Study of an Expandable Interbody Device for the Lumbar SpineNCT02075554results2021-02-03Fusion and Disc Height MaintenanceOpen-label · Treatment | Not applicable | Completed | Device: CALIBER | Degenerative Disc Disease | 58 | Nov 2016actual | — | 2021-02-03 |
| A Prospective Randomized Postmarket Clinical Study of the TRANSITION Stabilization SystemNCT02184520results2021-03-15Fusion RatesRandomized · Open-label · Treatment | Not applicable | Terminated | Device: TRANSITION, REVERE | Acute Instabilities Thoracic, Lumbar and Sacral Spine, Chronic Instabilities Thoracic, Lumbar and Sacral Spine, Deformities of the Thoracic, Lumbar and Sacral Spine | 1 | 2016-10-20actual | — | 2021-03-15 |
| INDEPENDENCE Spacer for Lumbar FusionNCT02299323observationalRadiographic fusion evaluation | — | Completed | Device: INDEPENDENCE | Degenerative Disc Disease | 30 | Aug 2016actual | — | 2016-08-10 |
| Study Evaluating the Safety and Effectiveness of the FLEXUS(TM) Interspinous SpacerNCT01156675results2018-04-27Number of Participants With Less Pain/Disability Using the Zurich Claudication Questionnaire (ZCQ) ScoreRandomized · Single-masked · Treatment | Not applicable | Terminated | Device: FLEXUS(TM) Interspinous Spacer, XSTOP® Interspinous Spacer | Lumbar Spinal Stenosis | 215 | Jul 2015actual | — | 2018-06-01 |
| A Retrospective Study Using CALIBER® TLIF Expandable Spacer in the Treatment of DDD: 2 Year Follow-up.NCT02388022observationalradiographic evaluation | — | Completed | Device: Degenerative Disc Disease | Degenerative Disc Disease | 200 | Jan 2015actual | — | 2016-08-10 |
| SECURE®-C Cervical Artificial Disc Clinical Study/ SECURE-C Cervical Artificial Disc Postmarket Approval StudyNCT00882661results2017-06-09Individual Patient Overall SuccessRandomized · Single-masked · Treatment | Not applicable | Completed | Device: SECURE-C Cervical Artificial Disc, ASSURE Cervical plate and an allograft interbody spacer | Symptomatic Cervical Disc Disease | 380 | Apr 2010actual | — | 2017-06-09 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19